Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat
Open Access
- 1 December 2001
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 281 (6) , R2029-R2036
- https://doi.org/10.1152/ajpregu.2001.281.6.r2029
Abstract
Pressure overload, such as hypertension, to the heart causes pathological cardiac hypertrophy, whereas chronic exercise causes physiological cardiac hypertrophy, which is defined as athletic heart. There are differences in cardiac properties between these two types of hypertrophy. We investigated whether mRNA expression of various cardiovascular regulating factors differs in rat hearts that are physiologically and pathologically hypertrophied, because we hypothesized that these two types of cardiac hypertrophy induce different molecular phenotypes. We used the spontaneously hypertensive rat (SHR group; 19 wk old) as a model of pathological hypertrophy and swim-trained rats (trained group; 19 wk old, swim training for 15 wk) as a model of physiological hypertrophy. We also used sedentary Wistar-Kyoto rats as the control group (19 wk old). Left ventricular mass index for body weight was significantly higher in SHR and trained groups than in the control group. Expression of brain natriuretic peptide, angiotensin-converting enzyme, and endothelin-1 mRNA in the heart was significantly higher in the SHR group than in control and trained groups. Expression of adrenomedullin mRNA in the heart was significantly lower in the trained group than in control and SHR groups. Expression of β1-adrenergic receptor mRNA in the heart was significantly higher in SHR and trained groups than in the control group. Expression of β1-adrenergic receptor kinase mRNA, which inhibits β1-adrenergic receptor activity, in the heart was markedly higher in the SHR group than in control and trained groups. We demonstrated for the first time that the manner of mRNA expression of various cardiovascular regulating factors in the heart differs between physiological and pathological cardiac hypertrophy.Keywords
This publication has 40 references indexed in Scilit:
- Gq Signaling in Cardiac Adaptation and MaladaptationTrends in Cardiovascular Medicine, 1999
- Stimulation of the p38 Mitogen-activated Protein Kinase Pathway in Neonatal Rat Ventricular Myocytes by the G Protein–coupled Receptor Agonists, Endothelin-1 and Phenylephrine: A Role in Cardiac Myocyte Hypertrophy?The Journal of cell biology, 1998
- Pathological versus physiological left ventricular hypertrophy: A reviewJournal of Sports Sciences, 1998
- Protein Kinase C, but Not Tyrosine Kinases or Ras, Plays a Critical Role in Angiotensin II-induced Activation of Raf-1 Kinase and Extracellular Signal-regulated Protein Kinases in Cardiac MyocytesJournal of Biological Chemistry, 1996
- Endothelin-1 Is Involved in Mechanical Stress-induced Cardiomyocyte HypertrophyJournal of Biological Chemistry, 1996
- Angiotensin-Converting Enzyme and Genetic Hypertension: Cloning of Rat cDNAs and Characterization of the EnzymeBiochemical and Biophysical Research Communications, 1994
- Molecular Cloning and Biological Activities of Rat Adrenomedullin, a Hypotensive PeptideBiochemical and Biophysical Research Communications, 1993
- cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNABiochemical and Biophysical Research Communications, 1991
- Physiologic cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy in rats.Journal of Clinical Investigation, 1982
- Noninvasive evaluation of exercise training in college-age men.Circulation, 1981